Amphetamine-type Stimulants Withdrawal
Conditions
Interventions
Electroacupuncture group:Electroacupuncture.
Blank control group:With no treatment
Sponsors
Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-65 years old; (2) Meets the diagnostic criteria for ATS withdrawal symptoms mentioned above; (3) Conscious, without aphasia or intellectual disabilities, with an education level of primary school or above, able to understand the specific content of the scale and actively cooperate with treatment; (4) Not participating in any other clinical trials within 3 months; (5) Voluntarily sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) There is trauma or infection in the acupoint area receiving acupuncture; (2) Women preparing for pregnancy or during pregnancy and lactation; (3) Merge with other serious organic diseases (such as tumors, cardiovascular diseases, liver cirrhosis) or mental disorders (such as schizophrenia); (4) Those who cannot tolerate acupuncture and moxibustion and electroacupuncture treatment or are allergic to acupuncture and moxibustion and alcohol; (5) Individuals with severe infectious diseases such as HIV infection and hepatitis; (6) Simultaneously using amphetamine drugs, long-term and large-scale mixing of other types of drugs; (7) According to the judgment of the researchers, patients who cannot participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS); | — |
Secondary
| Measure | Time frame |
|---|---|
| neurofilament light chain (NfL);Neuron-Specific Enolase (NSE);S100 calcium binding protein b (S100b); | — |
Countries
China
Contacts
Public ContactYulan Ren
Chengdu University of Traditional Chinese Medicine
Outcome results
None listed